Astec Lifesciences Share Price

Astec Lifesciences Share Price

NSE: ASTEC
|
Agrochemicals
|
S Cap
₹ 573.25
+₹0.70 (0.12%)
1D
Last updated 03 Sep, 2026, 15:29 IST

Astec Lifesciences Share Price Today

As of 4 Sep 2026, Astec Lifesciences share price is ₹573.25. The stock opened at ₹571.10, compared to its previous close of ₹572.55. During today's trading session, Astec Lifesciences share price moved in the range of ₹570.10 to ₹581.00, with an average price of ₹575.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹513.40 and a high of ₹941.75.

₹570.10
0.12% up today
₹581.00
1D LOW
1D HIGH

Astec Lifesciences Returns Calculator

Circuit
L
H
₹458.05
₹687.05
52-week
L
H
₹513.40
₹941.75

About Astec Lifesciences

Astec Lifesciences Share Price
ISIN
INE563J01010
Sector Market Cap
₹ 1,275.25 Cr

Astec LifeSciences Limited is an India-based company, which is engaged in the manufacturing of agrochemical active ingredients (technical), bulk, formulations and intermediate products. The Company undertakes contract development and manufacturing services for a diverse range of agrochemicals. The Company operates through a single segment, namely Agrochemicals. Its product categories include Fungicide, Growth Regulator, Intermediates, Insecticide, and Herbicide. Its products include Azimsulfuron, Halosulfuron, Flutriafol, Rimsulfuron, Transfluthrin, Prothiaconazole, Metalaxyl, Cyproconazole, and Tribenuron methyl. It has a sales mix of both exports and domestic sales. It exports to approximately 17 countries, including the United States and countries across Europe, West Asia, South-East Asia, Latin America and Africa. The Company has approximately nine manufacturing plants, which are located in Maharashtra.

Astec Lifesciences Financial Highlights

  • Revenue: Astec Lifesciences reported revenue of ₹453.22 crore in FY26 vs ₹386.93 crore in FY25. It showed an increase of 17.13% on a yearly basis.
  • Operating Profit: Astec Lifesciences reported an operating loss of ₹81.00 crore in FY26 vs ₹140.99 crore in FY25. It showed an increase of 42.55% on a year-on-year basis.
  • Net Profit: Astec Lifesciences reported a net loss of ₹80.88 crore in FY26 vs ₹134.71 crore in FY25. It showed an increase of 39.96% on a yearly basis.

Astec Lifesciences Quarterly Result Highlights

  • Astec Lifesciences reported revenue of ₹84.29 crore in Jun 2026, compared with ₹161.25 crore in Mar 2026, representing a decrease of 47.73% on a quarter-on-quarter (QoQ) basis.
  • Astec Lifesciences reported an operating loss of ₹18.74 crore in Jun 2026, compared with ₹7.90 crore in Mar 2026, representing a decrease of 137.22% on a quarter-on-quarter (QoQ) basis.
  • Astec Lifesciences reported a loss of ₹18.71 crore in Jun 2026, compared with ₹7.75 crore in Mar 2026, reflecting a decrease of 141.42% on a QoQ basis.
  • The earnings per share (EPS) of Astec Lifesciences stood at ₹37.79 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
71.96%
FII
0.01%
Other DII
0.31%
Retail and other
24.69%
Mutual funds
3.02%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.04%
Mar 20260.02%
Jun 20260.01%
Mkt Cap Cr
1,275.25
P/E
-19.16
P/B
3.26
ROE
-20.72%
D/E
1.15
ROCE
-5.54%
Div. Yield
0.00%
EPS(TTM)
-37.83
Turnover
0.47
EV/EBITDA
187.97
Net Margin
-18.08%
Op. Margin
-0.36%
ROA
-7.07%
Quick Ratio
0.61
Curr. Ratio
4.38
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Astec Lifescienc has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Astec Lifescienc appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Astec Lifescienc earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
UPL48,613.1020.921.405.54%0.0611.23%166.321.04%0.319.46
PI Industries36,269.0031.123.2311.76%0.0114.62%749.350.63%0.4694.57
Sumitomo Chemical India25,206.9042.957.3416.02%0.0221.30%67.800.26%0.7210.88
Bayer CropScience1,044.3824.446.0315.80%0.0320.08%659.903.76%0.98153.35
Sharda Cropchem7,023.2111.222.2421.71%0.0027.03%321.491.94%0.8975.07
Dhanuka Agritech4,431.9819.624.1522.34%0.0228.43%377.260.20%0.9363.72
Rallis India4,627.3928.192.739.99%0.0313.01%105.051.43%0.899.46
NACL Industries3,922.40315.945.742.49%0.427.39%31.390.00%1.051.04
BHAGIRADHA CHEM & INDS L3,474.48125.944.962.60%0.134.13%55.800.06%0.602.02
GSP CROP SCIENCE LIMITED2,914.8629.583.7812.69%0.2915.86%157.890.16%1.1022.88

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Astec Lifesciences Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹448.15₹381.30₹458.18₹628.17
Other Income₹5.07₹5.63₹5.64₹13.06
Total Revenue₹453.22₹386.93₹463.82₹641.23
Total Expenses₹532.12₹527.92₹525.57₹606.28
Profit Before Tax-₹81.00-₹140.99-₹61.75₹34.95
Tax-₹0.12-₹6.28-₹14.86₹9.35
Profit After Tax-₹80.88-₹134.71-₹46.89₹25.59
EPS - Basic-₹37.79-₹68.71-₹23.93₹13.04
EPS - Diluted-₹37.79-₹68.71-₹23.93₹13.04

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹81.00-₹140.99-₹61.75₹34.95
Income before WC changes-₹2.21-₹39.92₹1.69₹85.45
Change in Assets-₹85.17₹35.32₹101.00₹10.12
Change in Liabilities₹7.27-₹8.80-₹90.50-₹16.03
Change in WC-₹77.90₹26.53₹10.49-₹5.91
Cash flow from Operations-₹80.71-₹8.40₹10.22₹74.66
Cash flow from Investing-₹4.31-₹15.23-₹135.18-₹112.51
Cash flow from Financing₹94.49₹23.73₹124.96₹37.77
Total Cash Flow₹9.47₹0.10₹0.00-₹0.08
Cash (Start of the year)₹0.58₹0.47₹0.47₹0.55
Cash (End of the year)₹10.05₹0.58₹0.47₹0.47

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹499.05₹540.29₹576.44₹480.56
Current Assets₹442.99₹341.14₹398.49₹498.85
Total Assets₹942.04₹881.42₹974.93₹979.41
Current Liabilities₹499.79₹365.71₹397.16₹526.20
Net Current Asset-₹56.80-₹24.57₹1.33-₹27.35
Non-Current Liabilities₹51.33₹280.69₹208.25₹33.66
Equity Capital₹390.92₹235.02₹369.52₹419.56
Total Equity & Liabilities₹942.04₹881.42₹974.93₹979.41

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹448.15₹381.30₹458.18₹628.17
Other Income₹4.99₹5.56₹5.58₹13.04
Total Revenue₹453.13₹386.86₹463.76₹641.20
Total Expenses₹532.21₹527.98₹525.64₹606.35
Profit Before Tax-₹81.17-₹141.12-₹61.88₹34.85
Tax-₹0.16-₹6.31-₹14.89₹9.33
Profit After Tax-₹81.01-₹134.81-₹46.99₹25.52
EPS - Basic-₹37.83-₹68.74-₹23.96₹13.02
EPS - Diluted-₹37.83-₹68.74-₹23.96₹13.02

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹81.17-₹141.12-₹61.88₹34.85
Income before WC changes-₹2.19-₹39.91₹1.70₹85.46
Change in Assets-₹85.07₹35.32₹100.89₹10.11
Change in Liabilities₹7.23-₹8.83-₹90.53-₹16.39
Change in WC-₹77.84₹26.48₹10.36-₹6.28
Cash flow from Operations-₹80.59-₹8.39₹10.13₹74.32
Cash flow from Investing-₹4.32-₹15.13-₹134.98-₹112.07
Cash flow from Financing₹94.38₹23.62₹124.85₹37.66
Total Cash Flow₹9.47₹0.10₹0.00-₹0.09
Cash (Start of the year)₹0.57₹0.46₹0.46₹0.54
Cash (End of the year)₹10.04₹0.57₹0.46₹0.46

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹499.56₹540.46₹576.67₹480.75
Current Assets₹441.66₹339.96₹397.48₹498.09
Total Assets₹941.22₹880.42₹974.15₹978.85
Current Liabilities₹499.78₹365.69₹397.25₹526.33
Net Current Asset-₹58.11-₹25.73₹0.23-₹28.23
Non-Current Liabilities₹51.58₹280.66₹208.22₹33.73
Equity Capital₹389.87₹234.07₹368.68₹418.79
Total Equity & Liabilities₹941.22₹880.42₹974.15₹978.85
* All values are in INR Crore
Qty
Bid
50
573.25
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 50
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
32.68
Neutral
ATR (14)
26.24
Neutral
STOCH(9,6)
30.47
Neutral
STOCH RSI (14)
67.14
Neutral
ADX(9)
50.52
Bearish
UO(9)
34.72
Neutral
ROC(12)
-2.59
Bearish
WillR(14)
-72.43
Neutral
Period
Simple value
Exponential vaue
5D
569.5
572.39
10D
581.87
579.5
20D
592.54
594.39
50D
642.19
632.64
100D
689.79
656.73
Volume trend — traded volume by day
3 Sep0L
2 Sep0L
1 Sep0L
31 Aug0L
28 Aug0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
Astec Lifesciences Share Price
Astec Lifesciences
Agrochemicals
Add Stock
Add Another

Astec Lifesciences Share Price FAQs

Astec Lifesciences share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837